Australia markets open in 7 hours 50 minutes

Catalyst Biosciences, Inc. (CBIO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.6500+0.1400 (+3.99%)
As of 11:09AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close3.5100
Open3.5100
Bid3.6400 x 1100
Ask3.6500 x 1200
Day's range3.5100 - 3.7200
52-week range3.2500 - 7.5500
Volume55,130
Avg. volume313,873
Market cap114.485M
Beta (5Y monthly)2.02
PE ratio (TTM)N/A
EPS (TTM)-2.9740
Earnings date03 Nov 2021 - 08 Nov 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend date20 Aug 2015
1y target est16.60
  • GlobeNewswire

    Catalyst Biosciences Announces Chief Financial Officer Transition

    SOUTH SAN FRANCISCO, Calif., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that its chief financial officer, Clinton Musil, has resigned for personal reasons effective October 29, 2021. Seline Miller, the Company’s controller, has been promoted to senior vice president, finance and will serve as interim chief financial and principal accounting officer while the Company initiates a search for a successor. “I would like to thank Clinton for his many co

  • GlobeNewswire

    FDA Grants Catalyst Biosciences Orphan Drug Designation for MarzAA for the Treatment of Factor VII Deficiency

    SOUTH SAN FRANCISCO, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Disease Designation (ODD) for its lead product candidate, subcutaneous Marzeptacog alfa (activated), or MarzAA, for the treatment of Factor VII Deficiency (FVIID). MarzAA was previously granted ODD and Fast Track Designation (FTD) for treatment of Hemophilia A/B with inhibitors and FTD for the treatment

  • GlobeNewswire

    Catalyst Biosciences to Present at the Cantor Global Healthcare Conference

    SOUTH SAN FRANCISCO, Calif., Sept. 24, 2021 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that a fireside chat including members of its executive management team will be broadcast as part of the Cantor Global Healthcare Conference at 10:00 am ET on Wednesday, September 29, 2021. To access the webcast of the discussion, please click here. An archived webcast of the discussion will be available for 90 days on the Events and Presentations section of Catalyst’s websit